Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Biomed-Lublin Wytwornia Surowic i Szczepionek

Biomed-Lublin Wytwornia Surowic i Szczepionek

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
Stock Exchange	Warsaw Stock Exchange
EPS	PLN0.5
Market Cap	PLN62.26 M
Shares Outstanding	62.26 M
Public Float	-

Profile

Address	ul. Uniwersytecka 10 Lublin LU 20 Poland
Employees	-
Website	http://www.biomed.lublin.pl
Updated	07/08/2019
Biomed-Lublin Wytwornia Surowic I Szczepionek SA engages in the manufacture of pharmaceutical products. Its products include prescription and over-the-counter medicines, medical devices and laboratory reagents. The company was founded on December 4, 1944 and is headquartered in Lublin, Poland.

Financials

Jaroslaw Blaszczak

Chairman-Supervisory Board

Joanna Szymañska-Bulska

Member-Supervisory Board